Irenic Capital Management LP Theravance Biopharma, Inc. Transaction History
Irenic Capital Management LP
- $1.14 Trillion
- Q3 2024
A detailed history of Irenic Capital Management LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Irenic Capital Management LP holds 2,760,948 shares of TBPH stock, worth $27.2 Million. This represents 1.95% of its overall portfolio holdings.
Number of Shares
2,760,948
Previous 2,760,948
-0.0%
Holding current value
$27.2 Million
Previous $23.4 Billion
4.95%
% of portfolio
1.95%
Previous 2.86%
Shares
3 transactions
Others Institutions Holding TBPH
# of Institutions
122Shares Held
47.3MCall Options Held
200Put Options Held
12.8K-
Madison Avenue Partners, LP New York, NY9.51MShares$93.8 Million9.44% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$73.5 Million1.94% of portfolio
-
Newtyn Management, LLC New York, NY4.5MShares$44.4 Million6.4% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$37.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$20.2 Million0.0% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $658M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...